In a latest note to investors, a research analyst has provided a rating update for the Canopy Growth Corporation (WEED). Today, analyst John Chu gave a Hold rating to WEED and set a C$59 price target.
According to TipRanks.com, Chu is ranked #4709 out of 5229 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Canopy Growth Corporation with a C$76.83 average price target, implying a 43.9% upside from current levels. In a report issued on June 23, BMO Capital also maintained a Hold rating on the stock.
.
The company has a one-year high of C$76.68 and a one-year low of C$31.81. Currently, Canopy Growth Corporation has an average volume of 2.17M.
Canopy Growth Corp. engages in the production and sale of medical cannabis. The company offers products including oils and concentrates, soft gel capsules and hemp. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite.
The company’s shares closed on Thursday at C$53.38.
